Surgical Treatment of Supraclavicular and Internal Mammary Recurrence of Breast Cancer
Publication date: April 2018Source: Cirugía Española (English Edition), Volume 96, Issue 4Author(s): Alejandra de Andrés Gómez, Francisco Villalba Ferrer, Carla Navarro Moratalla, Ricardo Guijarro Jorge, Carlos Fuster Diana
Publication date: Available online 20 November 2019Source: European Journal of Surgical OncologyAuthor(s): Isabel T. Rubio, Michalis Kontos, M.J. Vrancken-Peeters, Roman Rouzier, Anita Rohini, Viviana Galimberti, Niels Kroman, Carmela Caballero, Shinji Ohno, BIG Task Force Surgical Trials
Conclusions: Although liquid biopsy remains challenging, a combination of SPAG6, NKX2-6, ITIH5 and PER1 (SNiPER) provides a promising tool for blood-based breast cancer detection. PMID: 31741713 [PubMed]
ConclusionsTumor-nipple enhancement and tumor-nipple distance on MRI could predict NAC involvement in breast cancer. When enhancement was evaluated on both early and delayed phase images with a combined tumor-nipple distance of ≤1 cm, the prediction of NAC involvement showed the best performance.
Conditions: Breast Cancer; DCIS Intervention: Device: LifeExtend-AI Sponsor: Indiana University Not yet recruiting
Condition: Breast Cancer Female Interventions: Drug: Metformin Hydrochloride 850 mg Tablets; Drug: AC-T chemotherapy regimen Sponsors: Damanhour University; Alexandria University Recruiting
Conditions: Breast Cancer; Morbid Obesity; Bariatric Surgery Candidate Intervention: Procedure: Bariatric surgery Sponsor: The Cleveland Clinic Not yet recruiting
Conditions: Breast Carcinoma; Mammoplasty Patient Interventions: Other: Diary; Other: Questionnaire Administration Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI) Recruiting
ConclusionFor women both with and without diagnosed breast cancer, cost was a major concern in seeking medical services. Affordability and access to breast cancer screening and treatment need to be improved. Providing more comprehensive insurance coverage is a key solution.
Radionecrosis has emerged as a side effect of SRS in patients with breast cancer brain metastases. Here, we look at its challenges and treatments.Medscape Oncology
Conclusion: Addition of emodin attenuated tamoxifen's treatment effect via cyclin D1 and pERK up-regulation in ER-positive breast cancer cell lines. PMID: 31742207 [PubMed]